Statistics
Publications
11
Citations
730
H-Index
11
Active since
1988
Heidi Schalch is an author at University of Wisconsin–Madison specializing in medicine, oncology, and cancer immunotherapy.
Publications per year
1988–2012
11
11
Phase I Clinical Trial of the Immunocytokine EMD 273063 in Melanoma Patients
David M. King, Mark R. Albertini, Heidi Schalch et al. · Journal of Clinical Oncology · 2004 · 146 citations · Full text
Medicine, Oncology, Pharmacology +17
Intratumoral injection of IL-12 plasmid DNA – results of a phase I/IB clinical trial
David M. Mahvi, Mary Beth Henry, Mark R. Albertini et al. · Cancer Gene Therapy · 2007 · 109 citations
Life Sciences, Immunology, Oncology +14
Phase II trial of hu14.18-IL2 for patients with metastatic melanoma
Mark R. Albertini, Jacquelyn A. Hank, Brian Gadbaw et al. · Cancer Immunology Immunotherapy · 2012 · 77 citations · Full text
Medicine, Immunology, Oncology +14
1–5 of 11